RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $111,000 | -3.5% | 94,343 | -7.6% | 0.00% | 0.0% |
Q2 2022 | $115,000 | -78.2% | 102,065 | -42.2% | 0.00% | -83.3% |
Q1 2022 | $528,000 | +0.8% | 176,448 | -10.8% | 0.01% | 0.0% |
Q4 2021 | $524,000 | +1.4% | 197,904 | -8.1% | 0.01% | -25.0% |
Q3 2020 | $517,000 | +22.8% | 215,434 | -6.3% | 0.01% | +33.3% |
Q2 2020 | $421,000 | -11.4% | 229,964 | -24.5% | 0.01% | -14.3% |
Q1 2020 | $475,000 | -34.8% | 304,725 | -10.4% | 0.01% | +16.7% |
Q4 2019 | $728,000 | +16.5% | 340,255 | +1.8% | 0.01% | +20.0% |
Q3 2019 | $625,000 | -31.5% | 334,246 | -4.5% | 0.01% | -28.6% |
Q2 2019 | $913,000 | +341.1% | 349,950 | +251.5% | 0.01% | +250.0% |
Q1 2016 | $207,000 | -41.4% | 99,558 | -14.6% | 0.00% | -33.3% |
Q4 2015 | $353,000 | -89.7% | 116,619 | -15.8% | 0.00% | -25.0% |
Q3 2015 | $3,422,000 | +1117.8% | 138,531 | +58.3% | 0.00% | +100.0% |
Q2 2015 | $281,000 | +80.1% | 87,490 | +100.3% | 0.00% | +100.0% |
Q1 2015 | $156,000 | – | 43,674 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |